Literature DB >> 17149425

Estimation of pharmacokinetic parameters based on the patient-adjusted population data.

Reza Mehvar1.   

Abstract

Population pharmacokinetic data, adjusted for patient characteristics, are recommended for the design of initial dosage regimens of some therapeutically monitored drugs in patients for whom patient-specific data are not available. However, despite widespread use by clinicians such as pharmacists, a clear understanding of the principles of population pharmacokinetics, including data collection and analysis and its limitations, is often lacking. This article describes the 2 main methods of obtaining population kinetic data, namely the two-stage method and nonlinear mixed effect model, and their applications to the pharmacokinetic-based design of dosage regimens. Additionally, some numerical examples are provided to assist the reader in understanding the material. The author uses these tools in a pharmacokinetics course taught to PharmD students.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149425      PMCID: PMC1637006          DOI: 10.5688/aj700596

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  16 in total

1.  Digoxin pharmacokinetics: role of renal failure in dosage regimen design.

Authors:  J R Koup; W J Jusko; C M Elwood; R K Kohli
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

2.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Proceedings: Digoxin dosage in patients with impaired kidney function.

Authors:  L Dettli; E E Ohnhaus; P Spring
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

4.  Premarketing observational studies of population pharmacokinetics of new drugs.

Authors:  L B Sheiner; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

5.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

6.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

Authors:  J R Powell; S Vozeh; P Hopewell; J Costello; L B Sheiner; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1978-08

Review 7.  An updated comparison of drug dosing methods. Part III: Aminoglycoside antibiotics.

Authors:  S M Erdman; K A Rodvold; R D Pryka
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 8.  An updated comparison of drug dosing methods. Part II: Theophylline.

Authors:  S M Erdman; K A Rodvold; R D Pryka
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

9.  Amikacin pharmacokinetics in morbidly obese patients.

Authors:  L A Bauer; R A Blouin; W O Griffen; K E Record; R M Bell
Journal:  Am J Hosp Pharm       Date:  1980-04

10.  Amikacin serum concentrations: prediction of levels and dosage guidelines.

Authors:  F A Sarubbi; J H Hull
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

View more
  4 in total

Review 1.  Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability.

Authors:  Oskar Estradé; Valvanera Vozmediano; Nerea Carral; Arantxa Isla; Margarita González; Rachel Poole; Elena Suarez
Journal:  Antibiotics (Basel)       Date:  2022-05-11

2.  Computational opioid prescribing: a novel application of clinical pharmacokinetics.

Authors:  Oscar A Linares; Annemarie L Linares
Journal:  J Pain Palliat Care Pharmacother       Date:  2011

Review 3.  Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring.

Authors:  Dion R Brocks; Dalia A Hamdy
Journal:  Res Pharm Sci       Date:  2020-11-27

4.  Efficiency of individual dosage of digoxin with calculated concentration.

Authors:  Li Zhao; Peng Yang; Pengmei Li; Xiaoxing Wang; Wangjun Qin; Xianglin Zhang
Journal:  Clin Interv Aging       Date:  2014-07-22       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.